Correlation Between EvoAir Holdings and Apogee Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EvoAir Holdings and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EvoAir Holdings and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EvoAir Holdings and Apogee Therapeutics, Common, you can compare the effects of market volatilities on EvoAir Holdings and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EvoAir Holdings with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of EvoAir Holdings and Apogee Therapeutics,.

Diversification Opportunities for EvoAir Holdings and Apogee Therapeutics,

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between EvoAir and Apogee is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding EvoAir Holdings and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and EvoAir Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EvoAir Holdings are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of EvoAir Holdings i.e., EvoAir Holdings and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between EvoAir Holdings and Apogee Therapeutics,

Assuming the 90 days horizon EvoAir Holdings is expected to generate 41.92 times less return on investment than Apogee Therapeutics,. But when comparing it to its historical volatility, EvoAir Holdings is 23.23 times less risky than Apogee Therapeutics,. It trades about 0.05 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1,700  in Apogee Therapeutics, Common on September 3, 2024 and sell it today you would earn a total of  2,914  from holding Apogee Therapeutics, Common or generate 171.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy73.89%
ValuesDaily Returns

EvoAir Holdings  vs.  Apogee Therapeutics, Common

 Performance 
       Timeline  
EvoAir Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EvoAir Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, EvoAir Holdings is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

EvoAir Holdings and Apogee Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EvoAir Holdings and Apogee Therapeutics,

The main advantage of trading using opposite EvoAir Holdings and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EvoAir Holdings position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.
The idea behind EvoAir Holdings and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.